Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine

Monovalent inactivated 2009 H1N1 pandemic influenza vaccine was safe and provided overall seroprotection as a surrogate of efficacy. In patients older than 60 years with severe asthma, a 30-μg dose might be more appropriate.